Procurement Footprint
Glaxosmithkline — public-sector procurement footprint
From open OCDS records, AqlData resolved 410 name-spelling variants of Glaxosmithkline into one identity (137 legal entities) and mapped its public-sector footprint: 36 countries, ~$24.7B in awarded value, across 15,352+ tracked contracts (2003-02-03 – 2026-05-21).
36
countries
$24.7B
awarded value
15,352+
tracked contracts
1,938
public buyers
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| EU | 1,418 | 6,597.4 |
| IT | 2,559 | 5,680.2 |
| GB | 206 | 2,346.9 |
| ES | 1,273 | 2,078.9 |
| BE | 45 | 2,053.3 |
| DE | 139 | 1,668.2 |
| + 30 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Dirección General de la Salud | UY | 751 |
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | PT | 242 |
| Centro Hospitalar Vila Nova de Gaia - Espinho, E. P. E | PT | 194 |
| + 1,935 more buyers — every agency, contract-level | — | in full report |
Activity over time
2015900
2016687
2017869
20181,213
20191,178
20201,062
2021873
20221,835
20231,327
20241,234
2025543
202629
The full due-diligence report
All 36 countries, every one of 1,938 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Glaxosmithkline due-diligence brief, delivered within 24 hours.
Request a worked sample